CDKN2A testing threshold in a high‐risk Australian melanoma cohort: number of primaries, family history and young age of onset impact risk

Saved in:
Bibliographic Details
Published in:Journal of the European Academy of Dermatology and Venereology 2020-12, Vol.34 (12), p.e797-e798
Main Authors: McMeniman, E.K., Peach, E., Lee, K.J., Yanes, T., Jagirdar, K., Stark, M.S., Soyer, H.P., Duffy, D.L., McInerney‐Leo, A.M., Sturm, R.A.
Format: Article
Language:English
Subjects:
Age of Onset
Australia - epidemiology
Cyclin-Dependent Kinase Inhibitor p16 - genetics
Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Melanoma - epidemiology
Melanoma - genetics
Mutation
Skin Neoplasms - epidemiology
Skin Neoplasms - genetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3257-69aec38a8c233bdeff4f3da39d0231fb175d778d8d75aa6e505abf7841c121b13
cites cdi_FETCH-LOGICAL-c3257-69aec38a8c233bdeff4f3da39d0231fb175d778d8d75aa6e505abf7841c121b13
container_end_page e798
container_issue 12
container_start_page e797
container_title Journal of the European Academy of Dermatology and Venereology
container_volume 34
creator McMeniman, E.K.
Peach, E.
Lee, K.J.
Yanes, T.
Jagirdar, K.
Stark, M.S.
Soyer, H.P.
Duffy, D.L.
McInerney‐Leo, A.M.
Sturm, R.A.
description
doi_str_mv 10.1111/jdv.16627
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2400544393</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2400544393</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3257-69aec38a8c233bdeff4f3da39d0231fb175d778d8d75aa6e505abf7841c121b13</originalsourceid><addsrcrecordid>eNp1kMtO3DAYRi0EgoGy4AUqL6lEwJdcHHajodzVblq20Z_Ynpgm8dROirLjAVjwjDwJHgLs6o03R-fXdxA6oOSYhndyL_8d0zRl2Qaa0TgVESeCb6IZyVka5XmS76Bd7-8JIZQmYhvtcMZFGvN8hp4WZzc_2Bz3yvemW-K-dsrXtpHYdBhwbZb1y-OzM_4Png--d9AY6HCrGuhsC7iytXX9Ke6GtlQOW41XzrTgjPJHWENrmjE4fG_diKGTeLRDOAJLtUZt51WPTbuCqsfrE1_QlobGq_33fw_9Pv_-a3EZ3f68uFrMb6OKsySL0hxUxQWIinFeSqV1rLkEnkvCONUlzRKZZUIKmSUAqUpIAqXOREwrymhJ-R46nLwrZ_8OYXnRGl-pJoxSdvAFiwlJ4tCHB_TbhFbOeu-ULqaBY0FJsY5fhPjFW_zAfn3XDmWr5Cf5UTsAJxPwYBo1_t9UXJ_dTcpXxpyREw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2400544393</pqid></control><display><type>article</type><title>CDKN2A testing threshold in a high‐risk Australian melanoma cohort: number of primaries, family history and young age of onset impact risk</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>McMeniman, E.K. ; Peach, E. ; Lee, K.J. ; Yanes, T. ; Jagirdar, K. ; Stark, M.S. ; Soyer, H.P. ; Duffy, D.L. ; McInerney‐Leo, A.M. ; Sturm, R.A.</creator><creatorcontrib>McMeniman, E.K. ; Peach, E. ; Lee, K.J. ; Yanes, T. ; Jagirdar, K. ; Stark, M.S. ; Soyer, H.P. ; Duffy, D.L. ; McInerney‐Leo, A.M. ; Sturm, R.A.</creatorcontrib><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/jdv.16627</identifier><identifier>PMID: 32386439</identifier><language>eng</language><publisher>England</publisher><subject>Age of Onset ; Australia - epidemiology ; Cyclin-Dependent Kinase Inhibitor p16 - genetics ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Humans ; Melanoma - epidemiology ; Melanoma - genetics ; Mutation ; Skin Neoplasms - epidemiology ; Skin Neoplasms - genetics</subject><ispartof>Journal of the European Academy of Dermatology and Venereology, 2020-12, Vol.34 (12), p.e797-e798</ispartof><rights>2020 European Academy of Dermatology and Venereology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3257-69aec38a8c233bdeff4f3da39d0231fb175d778d8d75aa6e505abf7841c121b13</citedby><cites>FETCH-LOGICAL-c3257-69aec38a8c233bdeff4f3da39d0231fb175d778d8d75aa6e505abf7841c121b13</cites><orcidid>0000-0002-9000-3226</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32386439$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McMeniman, E.K.</creatorcontrib><creatorcontrib>Peach, E.</creatorcontrib><creatorcontrib>Lee, K.J.</creatorcontrib><creatorcontrib>Yanes, T.</creatorcontrib><creatorcontrib>Jagirdar, K.</creatorcontrib><creatorcontrib>Stark, M.S.</creatorcontrib><creatorcontrib>Soyer, H.P.</creatorcontrib><creatorcontrib>Duffy, D.L.</creatorcontrib><creatorcontrib>McInerney‐Leo, A.M.</creatorcontrib><creatorcontrib>Sturm, R.A.</creatorcontrib><title>CDKN2A testing threshold in a high‐risk Australian melanoma cohort: number of primaries, family history and young age of onset impact risk</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><subject>Age of Onset</subject><subject>Australia - epidemiology</subject><subject>Cyclin-Dependent Kinase Inhibitor p16 - genetics</subject><subject>Genetic Predisposition to Disease</subject><subject>Germ-Line Mutation</subject><subject>Humans</subject><subject>Melanoma - epidemiology</subject><subject>Melanoma - genetics</subject><subject>Mutation</subject><subject>Skin Neoplasms - epidemiology</subject><subject>Skin Neoplasms - genetics</subject><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kMtO3DAYRi0EgoGy4AUqL6lEwJdcHHajodzVblq20Z_Ynpgm8dROirLjAVjwjDwJHgLs6o03R-fXdxA6oOSYhndyL_8d0zRl2Qaa0TgVESeCb6IZyVka5XmS76Bd7-8JIZQmYhvtcMZFGvN8hp4WZzc_2Bz3yvemW-K-dsrXtpHYdBhwbZb1y-OzM_4Png--d9AY6HCrGuhsC7iytXX9Ke6GtlQOW41XzrTgjPJHWENrmjE4fG_diKGTeLRDOAJLtUZt51WPTbuCqsfrE1_QlobGq_33fw_9Pv_-a3EZ3f68uFrMb6OKsySL0hxUxQWIinFeSqV1rLkEnkvCONUlzRKZZUIKmSUAqUpIAqXOREwrymhJ-R46nLwrZ_8OYXnRGl-pJoxSdvAFiwlJ4tCHB_TbhFbOeu-ULqaBY0FJsY5fhPjFW_zAfn3XDmWr5Cf5UTsAJxPwYBo1_t9UXJ_dTcpXxpyREw</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>McMeniman, E.K.</creator><creator>Peach, E.</creator><creator>Lee, K.J.</creator><creator>Yanes, T.</creator><creator>Jagirdar, K.</creator><creator>Stark, M.S.</creator><creator>Soyer, H.P.</creator><creator>Duffy, D.L.</creator><creator>McInerney‐Leo, A.M.</creator><creator>Sturm, R.A.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9000-3226</orcidid></search><sort><creationdate>202012</creationdate><title>CDKN2A testing threshold in a high‐risk Australian melanoma cohort: number of primaries, family history and young age of onset impact risk</title><author>McMeniman, E.K. ; Peach, E. ; Lee, K.J. ; Yanes, T. ; Jagirdar, K. ; Stark, M.S. ; Soyer, H.P. ; Duffy, D.L. ; McInerney‐Leo, A.M. ; Sturm, R.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3257-69aec38a8c233bdeff4f3da39d0231fb175d778d8d75aa6e505abf7841c121b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age of Onset</topic><topic>Australia - epidemiology</topic><topic>Cyclin-Dependent Kinase Inhibitor p16 - genetics</topic><topic>Genetic Predisposition to Disease</topic><topic>Germ-Line Mutation</topic><topic>Humans</topic><topic>Melanoma - epidemiology</topic><topic>Melanoma - genetics</topic><topic>Mutation</topic><topic>Skin Neoplasms - epidemiology</topic><topic>Skin Neoplasms - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McMeniman, E.K.</creatorcontrib><creatorcontrib>Peach, E.</creatorcontrib><creatorcontrib>Lee, K.J.</creatorcontrib><creatorcontrib>Yanes, T.</creatorcontrib><creatorcontrib>Jagirdar, K.</creatorcontrib><creatorcontrib>Stark, M.S.</creatorcontrib><creatorcontrib>Soyer, H.P.</creatorcontrib><creatorcontrib>Duffy, D.L.</creatorcontrib><creatorcontrib>McInerney‐Leo, A.M.</creatorcontrib><creatorcontrib>Sturm, R.A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McMeniman, E.K.</au><au>Peach, E.</au><au>Lee, K.J.</au><au>Yanes, T.</au><au>Jagirdar, K.</au><au>Stark, M.S.</au><au>Soyer, H.P.</au><au>Duffy, D.L.</au><au>McInerney‐Leo, A.M.</au><au>Sturm, R.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CDKN2A testing threshold in a high‐risk Australian melanoma cohort: number of primaries, family history and young age of onset impact risk</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2020-12</date><risdate>2020</risdate><volume>34</volume><issue>12</issue><spage>e797</spage><epage>e798</epage><pages>e797-e798</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><cop>England</cop><pmid>32386439</pmid><doi>10.1111/jdv.16627</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-9000-3226</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0926-9959
ispartof Journal of the European Academy of Dermatology and Venereology, 2020-12, Vol.34 (12), p.e797-e798
issn 0926-9959
1468-3083
language eng
recordid cdi_proquest_miscellaneous_2400544393
source Wiley-Blackwell Read & Publish Collection
subjects Age of Onset
Australia - epidemiology
Cyclin-Dependent Kinase Inhibitor p16 - genetics
Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Melanoma - epidemiology
Melanoma - genetics
Mutation
Skin Neoplasms - epidemiology
Skin Neoplasms - genetics
title CDKN2A testing threshold in a high‐risk Australian melanoma cohort: number of primaries, family history and young age of onset impact risk
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T09%3A19%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CDKN2A%20testing%20threshold%20in%20a%20high%E2%80%90risk%20Australian%20melanoma%20cohort:%20number%20of%20primaries,%20family%20history%20and%20young%20age%20of%20onset%20impact%20risk&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=McMeniman,%20E.K.&rft.date=2020-12&rft.volume=34&rft.issue=12&rft.spage=e797&rft.epage=e798&rft.pages=e797-e798&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/jdv.16627&rft_dat=%3Cproquest_cross%3E2400544393%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3257-69aec38a8c233bdeff4f3da39d0231fb175d778d8d75aa6e505abf7841c121b13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2400544393&rft_id=info:pmid/32386439&rfr_iscdi=true